Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells
Moawad, M., Fahmy, A., Elsherbeni, E., Youssef, A., El-Ghannam, G. (2023). Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells. EKB Journal Management System, 66(10), 17-22. doi: 10.21608/ejchem.2023.191302.7548
Mahmoud Moawad; Ahmed M. Fahmy; El-Sayed A. Elsherbeni; Ahmed M. Youssef; Gamal El-Ghannam. "Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells". EKB Journal Management System, 66, 10, 2023, 17-22. doi: 10.21608/ejchem.2023.191302.7548
Moawad, M., Fahmy, A., Elsherbeni, E., Youssef, A., El-Ghannam, G. (2023). 'Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells', EKB Journal Management System, 66(10), pp. 17-22. doi: 10.21608/ejchem.2023.191302.7548
Moawad, M., Fahmy, A., Elsherbeni, E., Youssef, A., El-Ghannam, G. Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells. EKB Journal Management System, 2023; 66(10): 17-22. doi: 10.21608/ejchem.2023.191302.7548

Enhancing the Efficiency of Doxorubicin -Conjugated with gold nanocomposites for Active Targeting and Laser Treatment for Human Esophagus Cancer Cells

Egyptian Journal of Chemistry
Volume 66, Issue 10, October 2023, Page 17-22  XML PDF (1.91 MB)
Document Type: Original Article
DOI: 10.21608/ejchem.2023.191302.7548
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud Moawadorcid 1; Ahmed M. Fahmy1; El-Sayed A. Elsherbeniorcid 2; Ahmed M. Youssef email 3; Gamal El-Ghannam2
1Pathology Dept., National Cancer Institute, Cairo Univ. Egypt
2National Institute of Laser Enhanced Science, Cairo University, Giza, Egypt.
3Packaging Materials Department, National Research Centre, 33 El Bohouth St. (former El Tahrirst.), Dokki, Giza, Egypt, P.O. 12622
Abstract
Nanotechnology is being used in cancer treatment to deliver drugs to tumors, improve imaging, and detect cancer cells. Nanoparticles are being used to deliver drugs more effectively to tumors, while also reducing the side effects of the drugs. The current context shows the conceivable biomedical utility of gold nanoparticles (AuNPs) covered with doxorubicin (DOX) for double chemotherapy and photothermal therapy (PTT) of throat cancers (esophagus) in vitro. DOX as FDA-authorized anti-cancer drug was added to AuNPs to enhance the chemotherapy impact. The blended DOX - AuNPs showed exorbitant cytotoxicity at the cancer cells and strong light absorption for temperature expansion in vitro. In the wake of treating DOX– Au nanocomposites with inside the esophagus cell line, PTT-helped DOX-Au nanocomposites involved the fantastical cytotoxicity of the cell strains for 15 min after the laser treatment. Exceptionally cytotoxicity impact in esophagus cell line turned out to be more attractive due to specific light absorption with the aid of using the directed DOX-Au nanocomposites. Thusly, the proposed DOX-Au nanocomposites might be an ability nano-theranostic material for treating throat cancers. The gene expression levels withinside the esophagus cell line from every group with or without laser exposure have been compared individually with control group. Bax has been overexpressed in esophagus cell line organization post 15 min laser irradiation. Conversely, BCL-2 gene has been down regulated with the aid of using RT-PCR analysis post 15 min laser irradiation, while in comparison to control cell line.
Keywords
Laser; PTT; gold /DOX Nanocomposites; RT-PCR
Statistics
Article View: 164
PDF Download: 102